The verdict was issued Dec. 9 in the U.S. Delaware District Court. Jurors found that four DePuy products — Zero-P VA, Zero-P, Zero-P Natural and SynFix Evolution — infringed RSB Spine’s patents. Jurors also found DePuy hadn’t proven that patent infringement claims were invalid.
The verdict concludes litigation that began with a lawsuit filed by RSB Spine Aug. 13, 2019. The lawsuit said the four DePuy products, used for spinal fusions, violated patents related to RSB Spine’s InterPlate devices.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
